The latest insights into the US Cell Viability Assays Market Share reveal a rapidly evolving landscape, with the anticipated market size projected to reach 1535.6 USD by 2035. This substantial growth reflects a compound annual growth rate (CAGR) of 8.5%, highlighting the increasing significance of cell viability assays in drug development and personalized medicine. As research continues to...